Ceramides and Oxidized Lipids: Convergent Mediators of Cardiometabolic Pathogenesis

References

1. Hammerschmidt P. Brüning J.C. Contribution of specific ceramides to obesity-associated metabolic diseases. Cell. Mol. Life Sci. 2022 79 8 395 10.1007/s00018‑022‑04401‑3 35789435
   [Google Scholar]
2. Gaggini M. Ndreu R. Michelucci E. Rocchiccioli S. Vassalle C. Ceramides as mediators of oxidative stress and inflammation in cardiometabolic disease. Int. J. Mol. Sci. 2022 23 5 2719 10.3390/ijms23052719 35269861
   [Google Scholar]
3. Shalaby Y.M. Nakhal M.M. Afandi B. Al-Zohily B. Majed L. Kumar K.K. Emerald B.S. Sadek B. Akour A. Akawi N. Impact of sodium-glucose cotransporter-2 inhibitors on aging biomarkers and plasma ceramide levels in type 2 diabetes: Beyond glycemic control. Ann. Med. 2025 57 1 2496795 10.1080/07853890.2025.2496795 40289660
   [Google Scholar]
4. Rizo-Roca D. Henderson J.D. Zierath J.R. Metabolomics in cardiometabolic diseases: Key biomarkers and therapeutic implications for insulin resistance and diabetes. J. Intern. Med. 2025 297 6 584 607 10.1111/joim.20090 40289598
   [Google Scholar]
5. Vasile V.C. Meeusen J.W. Medina Inojosa J.R. Donato L.J. Scott C.G. Hyun M.S. Vinciguerra M. Rodeheffer R.R. Lopez-Jimenez F. Jaffe A.S. Ceramide scores predict cardiovascular risk in the community. Arterioscler. Thromb. Vasc. Biol. 2021 41 4 1558 1569 10.1161/ATVBAHA.120.315530 33596665
   [Google Scholar]
6. Kim Y. Lim J.H. Kim E.N. Hong Y.A. Park H.J. Chung S. Choi B.S. Kim Y.S. Park J.Y. Kim H.W. Park C.W. Adiponectin receptor agonist ameliorates cardiac lipotoxicity via enhancing ceramide metabolism in type 2 diabetic mice. Cell Death Dis. 2022 13 3 282 10.1038/s41419‑022‑04726‑8 35351872
   [Google Scholar]
7. Yang S. Wu Y. Ceramide metabolism and cardiovascular risk factors: Insights into therapeutic strategies. Front. Cardiovasc. Med. 2025 12 1656113 10.3389/fcvm.2025.1656113
   [Google Scholar]
8. Kucuk S. Niven J. Caamano J. Jones S.W. Camacho-Muñoz D. Nicolaou A. Mauro C. Unwrapping the mechanisms of ceramide and fatty acid-initiated signals leading to immune-inflammatory responses in obesity. Int. J. Biochem. Cell Biol. 2021 135 105972 10.1016/j.biocel.2021.105972 33864951
   [Google Scholar]
9. Song Y. Hou M. Li Z. Luo C. Ou J.S. Yu H. Yan J. Lu L. TLR4/NF-κB/Ceramide signaling contributes to Ox-LDL-induced calcification of human vascular smooth muscle cells. Eur. J. Pharmacol. 2017 794 45 51 10.1016/j.ejphar.2016.11.029 27876618
   [Google Scholar]
10. Ichi I. Takashima Y. Adachi N. Nakahara K. Kamikawa C. Harada-Shiba M. Kojo S. Effects of dietary cholesterol on tissue ceramides and oxidation products of apolipoprotein B-100 in ApoE-deficient mice. Lipids 2007 42 10 893 900 10.1007/s11745‑007‑3067‑z 17647040
    [Google Scholar]
11. Halasiddappa L.M. Koefeler H. Futerman A.H. Hermetter A. Oxidized phospholipids induce ceramide accumulation in RAW 264.7 macrophages: Role of ceramide synthases. PLoS One 2013 8 7 e70002 10.1371/journal.pone.0070002 23936132
    [Google Scholar]
12. Guerra I.M.S. Ferreira H.B. Diogo L. Moreira S. Bonciarelli S. Goracci L. Melo T. Domingues P. Domingues M.R. Moreira A.S.P. Lipidomic profiling of red blood cells in the mitochondrial fatty acid β-oxidation disorder MCADD reveals phospholipid and sphingolipid dysregulation. J. Proteome Res. 2025 24 9 4631 4642 10.1021/acs.jproteome.5c00308 40704861
    [Google Scholar]
13. Turpin S.M. Nicholls H.T. Willmes D.M. Mourier A. Brodesser S. Wunderlich C.M. Mauer J. Xu E. Hammerschmidt P. Brönneke H.S. Trifunovic A. LoSasso G. Wunderlich F.T. Kornfeld J.W. Blüher M. Krönke M. Brüning J.C. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab. 2014 20 4 678 686 10.1016/j.cmet.2014.08.002 25295788
    [Google Scholar]
14. Hilvo M. Vasile V.C. Donato L.J. Hurme R. Laaksonen R. Ceramides and ceramide scores: Clinical applications for cardiometabolic risk stratification. Front. Endocrinol. 2020 11 570628 10.3389/fendo.2020.570628 33133018
    [Google Scholar]
15. Mishra P.P. Mishra B.H. Lyytikäinen L.P. Hilvo M. Juonala M. Kähönen M. Hutri-Kähönen N. Fotiadis D.I. Raitakari O.T. Laaksonen R. Lehtimäki T. Assessment of plasma ceramides as predictor for subclinical atherosclerosis. Atheroscler. Plus 2021 45 25 31 10.1016/j.athplu.2021.09.005 36643994
    [Google Scholar]